itopride has been researched along with Gastroesophageal Reflux in 8 studies
Gastroesophageal Reflux: Retrograde flow of gastric juice (GASTRIC ACID) and/or duodenal contents (BILE ACIDS; PANCREATIC JUICE) into the distal ESOPHAGUS, commonly due to incompetence of the LOWER ESOPHAGEAL SPHINCTER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "After administration of itopride hydrochloride, the SF-36 mental health scale and GSRS indigestion syndrome score and constipation syndrome score were significantly improved compared to before administration (p < 0." | 9.12 | Effects of itopride hydrochloride and ranitidine in patients with functional dyspepsia: comparison between prokinetic and acid suppression therapies. ( Chiba, T; Chishima, R; Endo, M; Ikeda, K; Inomata, M; Kudara, N; Orii, S; Suzuki, K; Takagi, R; Terui, T; Tokunaga, Y, 2007) |
| "The purpose is to evaluate the effectiveness of itopride (IP) and domperidone (DP) in the treatment of patients with gastroesophageal reflux disease (GERD), in combination with diabetes mellitus (DM) type 1 and 2." | 5.17 | [Comparative data of prokinetics in treatment of gastroesophageal reflux disease in patients with diabetes]. ( Fedorchenko, IuL, 2013) |
| "The aim of the study was to evaluate and document the efficacy and tolerability of rabeto plus (FDC of rabeprazole and itopride) in management of functional dyspepsia." | 5.13 | Rabeto plus: a valuable drug for managing functional dyspepsia. ( Basu, M; Dabholkar, P; Ghosh, A; Halder, S; Mandal, A; Mandal, S, 2008) |
| "After administration of itopride hydrochloride, the SF-36 mental health scale and GSRS indigestion syndrome score and constipation syndrome score were significantly improved compared to before administration (p < 0." | 5.12 | Effects of itopride hydrochloride and ranitidine in patients with functional dyspepsia: comparison between prokinetic and acid suppression therapies. ( Chiba, T; Chishima, R; Endo, M; Ikeda, K; Inomata, M; Kudara, N; Orii, S; Suzuki, K; Takagi, R; Terui, T; Tokunaga, Y, 2007) |
| "The ENGIP-I study was conducted to investigate the efficacy, and safety of itopride in patients of gastro-oesophageal reflux disease." | 5.11 | Evaluation of new gastro-intestinal prokinetic (ENGIP-I) study. ( Bargaje, RS; Kulkarni, SS; Walwaikar, PP, 2005) |
| "Itopride is a newly developed prokinetic agent, which enhances gastric motility through both antidopaminergic and anti-acetylcholinesterasic actions." | 2.71 | Effect of itopride, a new prokinetic, in patients with mild GERD: a pilot study. ( Choi, CS; Choi, MG; Choi, SC; Kim, SW; Kim, TH; Kim, YS; Nah, YH; Seo, GS; Shon, YW, 2005) |
| "Itopride pre-treatment inhibited the meal-induced rise of transient LES relaxations (TLESRs)." | 1.37 | The effects of itopride on oesophageal motility and lower oesophageal sphincter function in man. ( Blondeau, K; Boecxstaens, V; Farré, R; Gasbarrini, A; Scarpellini, E; Tack, J; Vos, R, 2011) |
| " The gastro retentive dosage form of itiopride demonstrated significant antacid, anti-ulcer, and anti-GERD activity after 12 hours in comparison with the conventional dosage form." | 1.36 | Evaluation of anti-GERD activity of gastro retentive drug delivery system of itopride hydrochloride. ( Goyal, AK; Panda, PK; Rath, G; Satapathy, T, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Janiak, M | 1 |
| Fedorchenko, IuL | 1 |
| Ghosh, A | 1 |
| Halder, S | 1 |
| Mandal, S | 1 |
| Mandal, A | 1 |
| Basu, M | 1 |
| Dabholkar, P | 1 |
| Satapathy, T | 1 |
| Panda, PK | 1 |
| Goyal, AK | 1 |
| Rath, G | 1 |
| Scarpellini, E | 1 |
| Vos, R | 1 |
| Blondeau, K | 1 |
| Boecxstaens, V | 1 |
| Farré, R | 1 |
| Gasbarrini, A | 1 |
| Tack, J | 1 |
| Kim, YS | 1 |
| Kim, TH | 1 |
| Choi, CS | 1 |
| Shon, YW | 1 |
| Kim, SW | 1 |
| Seo, GS | 1 |
| Nah, YH | 1 |
| Choi, MG | 1 |
| Choi, SC | 1 |
| Walwaikar, PP | 1 |
| Kulkarni, SS | 1 |
| Bargaje, RS | 1 |
| Chiba, T | 1 |
| Tokunaga, Y | 1 |
| Ikeda, K | 1 |
| Takagi, R | 1 |
| Chishima, R | 1 |
| Terui, T | 1 |
| Kudara, N | 1 |
| Endo, M | 1 |
| Inomata, M | 1 |
| Orii, S | 1 |
| Suzuki, K | 1 |
5 trials available for itopride and Gastroesophageal Reflux
| Article | Year |
|---|---|
[Comparative data of prokinetics in treatment of gastroesophageal reflux disease in patients with diabetes].
Topics: Adult; Benzamides; Benzyl Compounds; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetes Mel | 2013 |
Rabeto plus: a valuable drug for managing functional dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Benzamides; Benzyl Compounds; Drug | 2008 |
Effect of itopride, a new prokinetic, in patients with mild GERD: a pilot study.
Topics: Adult; Benzamides; Benzyl Compounds; Female; Gastric Emptying; Gastroesophageal Reflux; Humans; Male | 2005 |
Evaluation of new gastro-intestinal prokinetic (ENGIP-I) study.
Topics: Adolescent; Adult; Aged; Benzamides; Benzyl Compounds; Female; Gastric Emptying; Gastroesophageal Re | 2005 |
Effects of itopride hydrochloride and ranitidine in patients with functional dyspepsia: comparison between prokinetic and acid suppression therapies.
Topics: Adult; Aged; Anti-Ulcer Agents; Benzamides; Benzyl Compounds; Dyspepsia; Female; Gastroesophageal Re | 2007 |
3 other studies available for itopride and Gastroesophageal Reflux
| Article | Year |
|---|---|
Itopride in treatment of laryngopharyngeal symptoms of gastroesophageal reflux disease.
Topics: Benzamides; Benzyl Compounds; Gastroesophageal Reflux; Humans; Laryngopharyngeal Reflux; Laryngoscop | 2021 |
Evaluation of anti-GERD activity of gastro retentive drug delivery system of itopride hydrochloride.
Topics: Alginates; Animals; Benzamides; Benzyl Compounds; Calcium Carbonate; Chemistry, Pharmaceutical; Dela | 2010 |
The effects of itopride on oesophageal motility and lower oesophageal sphincter function in man.
Topics: Adult; Benzamides; Benzyl Compounds; Cross-Over Studies; Double-Blind Method; Esophageal Sphincter, | 2011 |